HIV envelope-mediated,,CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS

Blood

Volumn 118, Issue 22, 2011, Pages 5824-5831

  Li, Haishan ^a   Pauza, C David ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; CASPASE; CHEMOKINE RECEPTOR CCR5; INTEGRIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL MEMBRANE; CONFORMATIONAL TRANSITION; DISEASE COURSE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ENVELOPE; VIRUS STRAIN;

EID: 82155183315     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-356535     Document Type: Article

References (56)

1. Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol. 2011;6: 223-48.
2. Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 2005; 434(7037):1148-1152. (Pubitemid 40663495)
3. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005;434(7037): 1093-1097. (Pubitemid 40663481)
4. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235-245.
5. Nair MP, Schwartz SA. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I. Cell Mol Biol (Noisy-legrand). 1997;43(7):969-979.
6. Peruzzi M, Azzari C, Rossi ME, De Martino M, Vierucci A. Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide. AIDS Res Hum Retroviruses. 2000;16(11):1067-1073. (Pubitemid 30461047)
7. Kottilil S, Shin K, Jackson JO, et al. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J Immunol. 2006; 176(2):1107-1114. (Pubitemid 43099712)
8. Li H, Peng H, Ma P, et al. Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China. Clin Infect Dis. 2008;46(9):1466- 1472.
9. Autran B, Triebel F, Katlama C, Rozenbaum W, Hercend T, Debre P. T cell receptor gamma/ delta+ lymphocyte subsets during HIV infection. Clin Exp Immunol. 1989;75(2):206-210. (Pubitemid 19074247)
10. Poccia F, Boullier S, Lecoeur H, et al. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. J Immunol. 1996; 157(1):449-461. (Pubitemid 26190580)
11. Wallace M, Scharko AM, Pauza CD, et al. Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections. Mol Med. 1997;3(1):60-71. (Pubitemid 27142525)
12. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol. 2000;1(4):285-289.
13. Vlahakis SR, Algeciras-Schimnich A, Bou G, et al. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest. 2001;107(2):207-215. (Pubitemid 32096837)
14. Algeciras-Schimnich A, Vlahakis SR, Villasis-Keever A, et al. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS. 2002;16(11):1467-1478. (Pubitemid 34804211)
15. Estaquier J, Idziorek T, de Bels F, et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A. 1994;91(20):9431-9435. (Pubitemid 24297928)
16. Meythaler M, Martinot A, Wang Z, et al. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol. 2009;83(2):572- 583.
17. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity. 2003;18(3):441-452. (Pubitemid 36351522)
18. Iida T, Igarashi T, Ichimura H, et al. Fas antigen expression and apoptosis of lymphocytes in macaques infected with simian immunodeficiency virus strain mac. Arch Virol. 1998;143(4):717- 729.
19. Velu V, Kannanganat S, Ibegbu C, et al. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol. 2007;81(11): 5819-5828. (Pubitemid 46847019)
20. Poonia B, Pauza CD, Salvato MS. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology. 2009;6:91.
21. Salvato MS, Yin CC, Yagita H, et al. Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. Clin Dev Immunol. 2007;2007:93462.
22. Velu V, Titanji K, Zhu B, et al. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature. 2009;458(7235):206-210.
23. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 2000;96(9):2951-2964.
24. Gougeon ML. Apoptosis as an HIV strategy to escape immune attack. Nat Rev Immunol. 2003; 3(5):392-404.
25. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996;384(6609): 529-534. (Pubitemid 26415922)
26. Perfettini JL, Castedo M, Roumier T, et al. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ. 2005;(12) suppl 1:916-923. (Pubitemid 41030606)
27. Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature. 1986;322(6078):470-474. (Pubitemid 16034020)
28. Enders PJ, Yin C, Martini F, et al. HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. AIDS Res Hum Retroviruses. 2003; 19(1):21-29. (Pubitemid 36398740)
29. Hebbeler AM, Propp N, Cairo C, et al. Failure to restore the Vgamma2-Jgamma1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). Clin Immunol. 2008; 128(3):349-357.
30. Chia WK, Freedman J, Li X, Salit I, Kardish M, Read SE. Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection. AIDS Res Hum Retroviruses. 1995;11(2):249-256.
31. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100(5):587-597.
32. Turville SG, Arthos J, Donald KM, et al. HIV gp120 receptors on human dendritic cells. Blood. 2001;98(8):2482-2488.
33. Liu Y, Liu H, Kim BO, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004;78(8):4120-4133. (Pubitemid 38437218)
34. Cardona-Maya W, Lopez-Herrera A, Velilla-Hernandez P, Rugeles MT, Cadavid AP. The role of mannose receptor on HIV-1 entry into human spermatozoa. Am J Reprod Immunol. 2006;55(4):241-245. (Pubitemid 43349258)
35. Arthos J, Cicala C, Martinelli E, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol. 2008;9(3): 301-309. (Pubitemid 351267327)
36. Cicala C, Martinelli E, McNally JP, et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc Natl Acad Sci U S A. 2009;106(49):20877-20882.
37. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272(5263):872-877. (Pubitemid 26154590)
38. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381(6584): 667-673. (Pubitemid 26197680)
39. Glatzel A, Wesch D, Schiemann F, Brandt E, Janssen O, Kabelitz D. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells. J Immunol. 2002;168(10): 4920-4929. (Pubitemid 34498305)
40. Li H, Pauza CD. Rapamycin increases the yield and effector function of human gammadelta T cells stimulated in vitro. Cancer Immunol Immunother. 60(3):361-370.
41. Braun RK, Sterner-Kock A, Kilshaw PJ, Ferrick DA, Giri SN. Integrin alpha E beta 7 expression on BAL CD4+, CD8+, and gamma delta T-cells in bleomycin-induced lung fibrosis in mouse. Eur Respir J. 1996;9(4):673-679.
42. Heredia A, Gilliam B, DeVico A, et al. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1. AIDS. 2007;21(10):1317-13.
43. Wu L, Gerard NP, Wyatt R, et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 1996;384(6605):179-183. (Pubitemid 26386475)
44. Trkola A, Dragic T, Arthos J, et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 1996; 384(6605):184-187. (Pubitemid 26386476)
45. Biswas P, Tambussi G, Lazzarin A. Access denied? The status of co-receptor inhibition to counter HIV entry. Expert Opin Pharmacother. 2007; 8(7):923-933. (Pubitemid 351227480)
46. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004;21(4): 527-538. (Pubitemid 39370508)
47. Murooka TT, Wong MM, Rahbar R, Majchrzak- Kita B, Proudfoot AE, Fish EN. CCL5-CCR5-mediated apoptosis in T cells: requirement for glycosaminoglycan binding and CCL5 aggregation. J Biol Chem. 2006;281(35):25184-25194. (Pubitemid 44401905)
48. Choi WS, Eom DS, Han BS, et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and 9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem. 2004;279(19):20451- 20460. (Pubitemid 38623492)
49. Schrantz N, Bourgeade MF, Mouhamad S, Leca G, Sharma S, Vazquez A. p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41. Mol Biol Cell. 2001;12(10):3139-3151. (Pubitemid 33062968)
50. Trushin SA, Algeciras-Schimnich A, Vlahakis SR, et al. Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. J Immunol. 2007;178(8):4846-4853. (Pubitemid 46595266)
51. Kaul M, Ma Q, Medders KE, Desai MK, Lipton SA. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007;14(2):296-305. (Pubitemid 46092232)
52. Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV. G proteincoupled chemokine receptors induce both survival and apoptotic signaling pathways. J Immunol. 2002;169(10):5546-5554. (Pubitemid 35291653)
53. Parker CM, Groh V, Band H, et al. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med. 1990;171(5): 1597-1612. (Pubitemid 20167553)
54. Li D, Xu XN. NKT cells in HIV-1 infection. Cell Res. 2008;18(8):817-822.
55. Pauza CD, Riedel DJ, Gilliam BL, Redfield RR. Targeting gammadelta T cells for immunotherapy of HIV disease. Future Virol. 2011;6(1):73-84.
56. Riedel DJ, Sajadi MM, Armstrong CL, et al. Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells. AIDS. 2009;23(15):1955-1964.